144 related articles for article (PubMed ID: 31751824)
1. Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric Cancer.
Tong M; Yu C; Shi J; Huang W; Ge S; Liu M; Song L; Zhan D; Xia X; Liu W; Feng J; Shi W; Ji J; Gao J; Shi T; Zhu W; Ding C; Wang Y; He F; Shen L; Li T; Qin J
iScience; 2019 Dec; 22():44-57. PubMed ID: 31751824
[TBL] [Abstract][Full Text] [Related]
2. Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: Reanalysis of CPTAC ovarian cancer.
Tong M; Yu C; Zhan D; Zhang M; Zhen B; Zhu W; Wang Y; Wu C; He F; Qin J; Li T
EBioMedicine; 2019 Feb; 40():305-317. PubMed ID: 30594550
[TBL] [Abstract][Full Text] [Related]
3. Profiling Kinase Activities for Precision Oncology in Diffuse Gastric Cancer.
Singh S; Parthasarathi KTS; Bhat MY; Gopal C; Sharma J; Pandey A
OMICS; 2024 Feb; 28(2):76-89. PubMed ID: 38271566
[TBL] [Abstract][Full Text] [Related]
4. A proteomic landscape of diffuse-type gastric cancer.
Ge S; Xia X; Ding C; Zhen B; Zhou Q; Feng J; Yuan J; Chen R; Li Y; Ge Z; Ji J; Zhang L; Wang J; Li Z; Lai Y; Hu Y; Li Y; Li Y; Gao J; Chen L; Xu J; Zhang C; Jung SY; Choi JM; Jain A; Liu M; Song L; Liu W; Guo G; Gong T; Huang Y; Qiu Y; Huang W; Shi T; Zhu W; Wang Y; He F; Shen L; Qin J
Nat Commun; 2018 Mar; 9(1):1012. PubMed ID: 29520031
[TBL] [Abstract][Full Text] [Related]
5. Integrating proteomic and phosphoproteomic data for pathway analysis in breast cancer.
Ren J; Wang B; Li J
BMC Syst Biol; 2018 Dec; 12(Suppl 8):130. PubMed ID: 30577793
[TBL] [Abstract][Full Text] [Related]
6. Proteome-based molecular subtyping and therapeutic target prediction in gastric cancer.
Hu C; Song J; Kwok T; Nguyen EV; Shen X; Daly RJ
Mol Oncol; 2024 Apr; ():. PubMed ID: 38627210
[TBL] [Abstract][Full Text] [Related]
7. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
[TBL] [Abstract][Full Text] [Related]
8. Receptor Tyrosine Kinases Amplified in Diffuse-Type Gastric Carcinoma: Potential Targeted Therapies and Novel Downstream Effectors.
Yamaguchi H; Nagamura Y; Miyazaki M
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954414
[TBL] [Abstract][Full Text] [Related]
9. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice.
Park JW; Kim MS; Voon DC; Kim SJ; Bae J; Mun DG; Ko SI; Kim HK; Lee SW; Kim DY
Mol Carcinog; 2018 Jul; 57(7):947-954. PubMed ID: 29528141
[TBL] [Abstract][Full Text] [Related]
10. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K
World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982
[TBL] [Abstract][Full Text] [Related]
11. Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation.
Ishige T; Nishimura M; Satoh M; Fujimoto M; Fukuyo M; Semba T; Kado S; Tsuchida S; Sawai S; Matsushita K; Togawa A; Matsubara H; Kaneda A; Nomura F
Sci Rep; 2016 Feb; 6():21681. PubMed ID: 26892343
[TBL] [Abstract][Full Text] [Related]
12. Network Reconstruction and Significant Pathway Extraction Using Phosphoproteomic Data from Cancer Cells.
Buffard M; Naldi A; Radulescu O; Coopman PJ; Larive RM; Freiss G
Proteomics; 2019 Nov; 19(21-22):e1800450. PubMed ID: 31472481
[TBL] [Abstract][Full Text] [Related]
13. Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer.
Humar B; Fukuzawa R; Blair V; Dunbier A; More H; Charlton A; Yang HK; Kim WH; Reeve AE; Martin I; Guilford P
Cancer Res; 2007 Mar; 67(6):2480-9. PubMed ID: 17363565
[TBL] [Abstract][Full Text] [Related]
14. PGP9.5 methylation in diffuse-type gastric cancer.
Yamashita K; Park HL; Kim MS; Osada M; Tokumaru Y; Inoue H; Mori M; Sidransky D
Cancer Res; 2006 Apr; 66(7):3921-7. PubMed ID: 16585221
[TBL] [Abstract][Full Text] [Related]
15. Personalization of prostate cancer therapy through phosphoproteomics.
Yang W; Freeman MR; Kyprianou N
Nat Rev Urol; 2018 Aug; 15(8):483-497. PubMed ID: 29752463
[TBL] [Abstract][Full Text] [Related]
16. INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases.
Beekhof R; van Alphen C; Henneman AA; Knol JC; Pham TV; Rolfs F; Labots M; Henneberry E; Le Large TY; de Haas RR; Piersma SR; Vurchio V; Bertotti A; Trusolino L; Verheul HM; Jimenez CR
Mol Syst Biol; 2019 Apr; 15(4):e8250. PubMed ID: 30979792
[TBL] [Abstract][Full Text] [Related]
17. PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification.
Nagamura Y; Miyazaki M; Nagano Y; Yuki M; Fukami K; Yanagihara K; Sasaki K; Sakai R; Yamaguchi H
Oncogenesis; 2021 Mar; 10(3):25. PubMed ID: 33677467
[TBL] [Abstract][Full Text] [Related]
18. Phosphoproteomics reveals network rewiring to a pro-adhesion state in annexin-1-deficient mammary epithelial cells.
Alli-Shaik A; Wee S; Lim LHK; Gunaratne J
Breast Cancer Res; 2017 Dec; 19(1):132. PubMed ID: 29233185
[TBL] [Abstract][Full Text] [Related]
19. The novel long noncoding RNA RP11-357H14.17 acts as an oncogene by promoting cell proliferation and invasion in diffuse-type gastric cancer.
Yang B; Luo T; Zhang M; Lu Z; Xue X; Fang G
Onco Targets Ther; 2017; 10():2635-2643. PubMed ID: 28572735
[TBL] [Abstract][Full Text] [Related]
20. Comparison on Clinicopathological Features, Treatments and Prognosis between Proximal Gastric Cancer and Distal Gastric Cancer: A National Cancer Data Base Analysis.
Wang X; Liu F; Li Y; Tang S; Zhang Y; Chen Y; Khan SA
J Cancer; 2019; 10(14):3145-3153. PubMed ID: 31289585
[No Abstract] [Full Text] [Related]
[Next] [New Search]
